World News: 14:00 GMT Monday 16th April 2018. [TESARO, Inc. via Globe Newswire via SPi World News]
CHICAGO April 16 2018 GLOBE NEWSWIRE -- TESARO, Inc NASDAQTSRO an oncology-focused biopharmaceutical company today summarized initial data from the Phase 1 GARNET trial of TSR-042 anti-PD-1 antibody) in patients with microsatellite inst ability...
Globe Newswire: 14:00 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.